Measuring tumor metabolism by 18F-FDG PET predicts outcome in a multicenter study: a step off in the right direction. uri icon

Overview

publication date

  • January 1, 2015

Research

keywords

  • Antineoplastic Agents
  • Breast Neoplasms
  • Fluorodeoxyglucose F18
  • Positron-Emission Tomography
  • Receptor, ErbB-2

Identity

Scopus Document Identifier

  • 84920417232

Digital Object Identifier (DOI)

  • 10.2967/jnumed.114.151175

PubMed ID

  • 25537988

Additional Document Info

volume

  • 56

issue

  • 1